CytoDyn Inc. (OTCMKTS:CYDY – Get Free Report)’s stock price crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.17 and traded as low as $0.14. CytoDyn shares last traded at $0.15, with a volume of 1,476,035 shares changing hands.
CytoDyn Trading Up 5.8 %
The firm has a fifty day moving average price of $0.17 and a 200-day moving average price of $0.18.
CytoDyn (OTCMKTS:CYDY – Get Free Report) last posted its quarterly earnings data on Monday, April 15th. The biotechnology company reported ($0.01) earnings per share for the quarter.
CytoDyn Company Profile
CytoDyn Inc, a clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications. The company is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19, human immunodeficiency virus (HIV), Metabolic dysfunction-associated steatohepatitis (MASH), and solid tumors in oncology, such as metastatic triple-negative breast cancer.
See Also
- Five stocks we like better than CytoDyn
- Learn Technical Analysis Skills to Master the Stock Market
- MarketBeat Week in Review – 4/29 – 5/3
- What Are Dividend Achievers? An Introduction
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- What is the Nikkei 225 index?
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for CytoDyn Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CytoDyn and related companies with MarketBeat.com's FREE daily email newsletter.
